143 related articles for article (PubMed ID: 23721256)
1. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
2. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
[TBL] [Abstract][Full Text] [Related]
3. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus PARV4 visualization and detection.
Tuke PW; Parry RP; Appleton H
J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
[TBL] [Abstract][Full Text] [Related]
6. First report of human parvovirus 4 detection in Iran.
Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
8. Identification of human parvovirus 4 genotypes 1 and 2 in Chinese source plasma pools.
Jia J; Zhong Y; Zhang H; Yuan D; Ma L; Wang D; Zhang J; Ma Y
J Med Virol; 2021 Aug; 93(8):4780-4785. PubMed ID: 33200412
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
Juhl D; Görg S; Hennig H
Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
[TBL] [Abstract][Full Text] [Related]
10. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
Chen MY; Hung CC; Lee KL
Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
[TBL] [Abstract][Full Text] [Related]
11. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
13. Studies on the inactivation of human parvovirus 4.
Baylis SA; Tuke PW; Miyagawa E; Blümel J
Transfusion; 2013 Oct; 53(10 Pt 2):2585-92. PubMed ID: 24032592
[TBL] [Abstract][Full Text] [Related]
14. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
[TBL] [Abstract][Full Text] [Related]
15. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
16. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens.
Botto S; Bergallo M; Sidoti F; Terlizzi ME; Astegiano S; Ponti R; Costa C; Cavallo R
New Microbiol; 2009 Apr; 32(2):189-92. PubMed ID: 19579698
[TBL] [Abstract][Full Text] [Related]
17. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.
Slavov SN; Gonçalves de Noronha LA; Gonzaga FAC; Pimentel BMS; Kashima S; Haddad R
J Med Microbiol; 2019 Apr; 68(4):622-626. PubMed ID: 30843782
[TBL] [Abstract][Full Text] [Related]
18. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus PARV4 in plasma pools of Chinese origin.
Ma YY; Guo Y; Zhao X; Wang Z; Lv MM; Yan QP; Zhang JG
Vox Sang; 2012 Oct; 103(3):183-5. PubMed ID: 22458565
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
